Atul Dandekar
CSBO · Maze Therapeutics, Inc.
- 2025
- Oct 1, 2026
- 13
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Atul Dandekar files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Harold Bernstein - $7.44M in MAZE purchases and sales in the last 12 months
- Jason V. Coloma - $6.19M in MAZE purchases and sales in the last 12 months
- Catherine A. Sohn - $1.15M in MAZE purchases and sales in the last 12 months
- Amy Bachrodt - $757K in MAZE purchases and sales in the last 12 months
- Phillips Courtney - $105K in MAZE purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Atul Dandekar?
Atul Dandekar is a corporate insider, tracked as CSBO of Maze Therapeutics, Inc. (MAZE). InsiderAlpha holds 13 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Atul Dandekar submitted recently?
5 primary Form 4 filings in the last 90 days, covering 1 company.
Has Atul Dandekar been buying or selling stock?
Recorded transactions: 0 open-market purchases and 18 open-market sales ($2.27M) across all tracked filings.